Richard B. Bartram
2020
In 2020, Richard B. Bartram earned a total compensation of $2.5M as Former Chief Financial Officer at Esperion Therapeutics, a 407% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,000 |
|---|---|
| Option Awards | $1,470,247 |
| Salary | $400,000 |
| Stock Awards | $461,584 |
| Other | $9,750 |
| Total | $2,461,581 |
Bartram received $1.5M in option awards, accounting for 60% of the total pay in 2020.
Bartram also received $120K in non-equity incentive plan, $400K in salary, $461.6K in stock awards and $9.8K in other compensation.
Rankings
In 2020, Richard B. Bartram's compensation ranked 4,620th out of 13,090 executives tracked by ExecPay. In other words, Bartram earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,620 out of 13,090 | 65th |
Division Manufacturing | 1,878 out of 5,624 | 67th |
Major group Chemicals And Allied Products | 733 out of 2,257 | 68th |
Industry group Drugs | 628 out of 1,957 | 68th |
Industry Pharmaceutical Preparations | 475 out of 1,462 | 68th |
Source: SEC filing on April 14, 2022.
Bartram's colleagues
We found three more compensation records of executives who worked with Richard B. Bartram at Esperion Therapeutics in 2020.